Codexis (CDXS) Assets Average (2011 - 2026)
Codexis (CDXS) posted quarterly Assets Average of $138.6 million for Q1 2026, little changed year-over-year from $138.9 million in Q1 2025, and up 1.99% quarter-over-quarter from $135.9 million in Q4 2025.
Codexis (CDXS) Assets Average (2011 - 2026) Analysis & Trends
Codexis' Assets Average history runs 16 years deep, the most recent figure standing at $138.6 million for Q1 2026.
- In Q1 2026, Assets Average changed 0.26% year-over-year to $138.6 million; the TTM figure through Mar 2026 stood at $138.6 million (changed 0.26% YoY), while the FY2025 annual figure was $148.4 million, up 3.93% from the prior year.
- Assets Average for Q1 2026 stood at $138.6 million, up from $135.9 million in the prior quarter.
- The five-year high for Assets Average was $242.8 million in Q4 2022, with the low at $131.1 million in Q3 2025.
- The 5-year median for Assets Average is $145.5 million (2023), against an average of $175.1 million.
- The sharpest annual moves came in 2022 and 2023: Assets Average grew 11.03% in 2022, then sank 40.08% in 2023.
- Codexis' Assets Average stood at $242.8 million in 2022, then tumbled by 40.08% to $145.5 million in 2023, then increased by 2.12% to $148.6 million in 2024, then slipped by 8.56% to $135.9 million in 2025, then increased by 1.99% to $138.6 million in 2026.
- Business Quant data shows CDXS's Assets Average at $138.6 million in Q1 2026, $135.9 million in Q4 2025, and $131.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 19.82 Bn |
| 10 | Codexis | 146.14 Mn | 91.22 Mn | 11.40 Mn | 124.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 124.71 Mn |
| Mar 31, 2026 | 138.58 Mn |
| Dec 31, 2025 | 135.88 Mn |
| Sep 30, 2025 | 131.10 Mn |
| Jun 30, 2025 | 133.57 Mn |
| Mar 31, 2025 | 138.95 Mn |
| Dec 31, 2024 | 148.60 Mn |
| Sep 30, 2024 | 140.09 Mn |
| Jun 30, 2024 | 140.78 Mn |
| Mar 31, 2024 | 143.06 Mn |
| Dec 31, 2023 | 145.51 Mn |
| Sep 30, 2023 | 180.61 Mn |
| Jun 30, 2023 | 212.41 Mn |
| Mar 31, 2023 | 234.23 Mn |
| Dec 31, 2022 | 242.84 Mn |
| Sep 30, 2022 | 235.13 Mn |
| Jun 30, 2022 | 235.12 Mn |
| Mar 31, 2022 | 240.83 Mn |
| Dec 31, 2021 | 236.97 Mn |
| Sep 30, 2021 | 219.93 Mn |